Your browser doesn't support javascript.
loading
Localization of the cannabinoid type-1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus.
Gutiérrez-Rodríguez, Ana; Bonilla-Del Río, Itziar; Puente, Nagore; Gómez-Urquijo, Sonia M; Fontaine, Christine J; Egaña-Huguet, Jon; Elezgarai, Izaskun; Ruehle, Sabine; Lutz, Beat; Robin, Laurie M; Soria-Gómez, Edgar; Bellocchio, Luigi; Padwal, Jalindar D; van der Stelt, Mario; Mendizabal-Zubiaga, Juan; Reguero, Leire; Ramos, Almudena; Gerrikagoitia, Inmaculada; Marsicano, Giovanni; Grandes, Pedro.
Affiliation
  • Gutiérrez-Rodríguez A; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, E-48940, Spain.
  • Bonilla-Del Río I; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain.
  • Puente N; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, E-48940, Spain.
  • Gómez-Urquijo SM; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain.
  • Fontaine CJ; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, E-48940, Spain.
  • Egaña-Huguet J; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain.
  • Elezgarai I; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, E-48940, Spain.
  • Ruehle S; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain.
  • Lutz B; Division of Medical Sciences, University of Victoria, Victoria, British Columbia, V8P 5C2, Canada.
  • Robin LM; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, E-48940, Spain.
  • Soria-Gómez E; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain.
  • Bellocchio L; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, E-48940, Spain.
  • Padwal JD; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain.
  • van der Stelt M; Institute of Physiological Chemistry and German Resilience Center, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, 55128, Germany.
  • Mendizabal-Zubiaga J; Institute of Physiological Chemistry and German Resilience Center, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, 55128, Germany.
  • Reguero L; INSERM, U1215 Neurocentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, F-33077, France.
  • Ramos A; Université de Bordeaux, Bordeaux, F-33077, France.
  • Gerrikagoitia I; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, E-48940, Spain.
  • Marsicano G; Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain.
  • Grandes P; INSERM, U1215 Neurocentre Magendie, Endocannabinoids and Neuroadaptation, Bordeaux, F-33077, France.
Glia ; 66(7): 1417-1431, 2018 07.
Article de En | MEDLINE | ID: mdl-29480581
ABSTRACT
Astroglial type-1 cannabinoid (CB1 ) receptors are involved in synaptic transmission, plasticity and behavior by interfering with the so-called tripartite synapse formed by pre- and post-synaptic neuronal elements and surrounding astrocyte processes. However, little is known concerning the subcellular distribution of astroglial CB1 receptors. In particular, brain CB1 receptors are mostly localized at cells' plasmalemma, but recent evidence indicates their functional presence in mitochondrial membranes. Whether CB1 receptors are present in astroglial mitochondria has remained unknown. To investigate this issue, we included conditional knock-out mice lacking astroglial CB1 receptor expression specifically in glial fibrillary acidic protein (GFAP)-containing astrocytes (GFAP-CB1 -KO mice) and also generated genetic rescue mice to re-express CB1 receptors exclusively in astrocytes (GFAP-CB1 -RS). To better identify astroglial structures by immunoelectron microscopy, global CB1 knock-out (CB1 -KO) mice and wild-type (CB1 -WT) littermates were intra-hippocampally injected with an adeno-associated virus expressing humanized renilla green fluorescent protein (hrGFP) under the control of human GFAP promoter to generate GFAPhrGFP-CB1 -KO and -WT mice, respectively. Furthermore, double immunogold (for CB1 ) and immunoperoxidase (for GFAP or hrGFP) revealed that CB1 receptors are present in astroglial mitochondria from different hippocampal regions of CB1 -WT, GFAP-CB1 -RS and GFAPhrGFP-CB1 -WT mice. Only non-specific gold particles were detected in mouse hippocampi lacking CB1 receptors. Altogether, we demonstrated the existence of a precise molecular architecture of the CB1 receptor in astrocytes that will have to be taken into account in evaluating the functional activity of cannabinergic signaling at the tripartite synapse.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Astrocytes / Récepteur cannabinoïde de type CB1 / Hippocampe Limites: Animals Langue: En Journal: Glia Sujet du journal: NEUROLOGIA Année: 2018 Type de document: Article Pays d'affiliation: Espagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Astrocytes / Récepteur cannabinoïde de type CB1 / Hippocampe Limites: Animals Langue: En Journal: Glia Sujet du journal: NEUROLOGIA Année: 2018 Type de document: Article Pays d'affiliation: Espagne